Skip to main content
Premium Trial:

Request an Annual Quote

Waters Revenues, Income Up in Q1

NEW YORK, April 28 (GenomeWeb News) - Waters reported increased revenues and earnings for the first quarter today.

 

Revenues were $255 million, up from $221 million during the first quarter last year.

 

Research and development costs for the quarter increased to $16.1 million, up from $13.6 million during the first quarter last year.

 

Net income for the quarter was $40.8 million, or $.33 per share, up from $34 million, or $.26 per share, during the year-ago period.

 

As of March 31, Waters had $408.6 million in cash and cash equivalents.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.